Palliative Care

Quality of Supportive Care for Patients With Advanced Lung Cancer in the VHA

Author and Disclosure Information

 

References

About 8% of patients were diagnosed at a VAMC different from the VACCR attribution. Six percent received specialty service consultations or treatment at multiple VAMCs, and about 25% received at least one specialty service consultation or treatment at a non-VHA facility.

Quality Indicator Eligibility and Rates of Receiving Recommended Care

Patient eligibility for the quality indicators (Table 3) ranged from 1% (treatment of spinal cord compression) to 68% (prevention of chemotherapy-related nausea and vomiting). Few patients were eligible for palliative treatment indicators (palliative radiation therapy and treatment of spinal cord compression), with only 2% of patients (50 individuals) eligible for the imaging indicator. Eligibility for the two indicators related to use of shortacting opioids for break-through pain was also low (2%-4%).

Mean national rates for recommended support ive care were generally high (above 85% for 8 of the 12 indicators), ranging from 98% for outpatient pain screening to a low of 60% for spine MRI or myelography within 24 hours for suspected spinal cord compression (Table 3). There was pronounced variability across facilities, with facility rates in every domain ranging from 0%-100% (Figure 1). Many facilities scored 100% in at least 1 domain (eg, 44 of 109 facilities for pain screening; 51 of 94 for palliative cancer therapy). Eight (of 111) facilities did not provide recommended care in 1 domain and 1 did not provide recommended care in 2 domains (ie, 0% of recommended care).

In bivariate analyses (data not shown), referral to palliative care was associated with better care for treatment toxicity (P = .04) but not the other domains. Patients with poor performance status were more likely to be referred to hospice (81% vs 74% for those with good performance status, P = .005) as were patients who lived in an urban zip code area (77% vs 71% for rural zip code, P = .03). In multivariate analyses (Table 4), small-cell cancer type, though not significant in the bivariate analyses, was associated with a higher odds of receiving recommended care [OR, 2.71; 95% CI, 1.89-3.86)] in the
treatment toxicity domain and lower odds in the pain domain [OR, 0.50; 95% CI, 0.33-0.77)]; and poor performance remained associated with higher odds of referral to hospice [OR, 1.49; 95% CI, 1.12-1.99)] after adjusting for other patient and facility characteristics.

In multivariate analysis, moderate facility complexity was associated with lower quality in the toxicity domain than was low facility complexity [OR, 0.28; 95% CI, 0.18-0.44)]; however there was no such difference between the low- and high-complexity facilities. The presence of a patient tracking method appeared to be associated with better quality of care in the treatment toxicity domain [OR, 3.38; 95% CI, 1.87-6.10)] and a higher likelihood of referral to hospice [OR, 1.60; 95% CI, 1.22-2.28)] when the method was monitored by a midlevel practitioner (nurse practitioner or physician assistant), but no association was found for methods monitored by other types of staff. In the pain domain, having a psychologist specializing in cancer was associated with a higher odds of receiving recommended care [OR, 1.76; 95% CI, 1.16-2.66)]. No patient or facility characteristics were associated with receiving recommended palliative cancer therapy, although statistical power was limited by the small numbers of eligible events.

Pages

Recommended Reading

Impact of Demographic and Health System Variables on Survival in Early Stage (Stage I and II) Non-Small Cell Lung Carcinoma: A National Cancer Database Analysis
AVAHO
Pilot Study: Is In-Network Care for Veterans Diagnosed With Malignant Pleural Mesothelioma (MPM) Feasible With VAHCS?
AVAHO
An Unusual Cause of Shortness of Breath: Primary Tracheal Basal Cell Adenocarcinoma
AVAHO
Long-Term Survival of a Patient With Late-Stage Non-Small Cell Lung Cancer
AVAHO
Is It All in the Eye of the Beholder? Comparing Pulmonologists’ and Radiologists’ Performance
AVAHO
Metastatic Small Cell Carcinoma of the Lung: An Unusual Cause of Acute Fulminant Hepatic Failure
AVAHO
Long-Term Survival of a Patient With Late-Stage Non-Small Cell Lung Cancer
AVAHO
Examining the No. 1 Preventable Cause of Cancer
AVAHO
Shorter Length of Stay May Not Mean Higher Readmission Rates
AVAHO
Rare Cancer Gets Timely Right Treatment
AVAHO